• 1
    Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation. 2000;102:IV14IV23.
  • 2
    Aghababian RV. Acutely decompensated heart failure: opportunities to improve care and outcomes in the emergency department. Rev Cardiovasc Med. 2002;3:S3S9.
  • 3
    Sauve MJ, Lewis WR, Blankenbiller M, et al.Cognitive impairments in chronic heart failure: a case controlled study. J Card Fail. 2009;15:110.
  • 4
    Qiu C, Winblad B, Marengoni A, et al.Heart failure and the risk of dementia and Alzheimer disease. Arch Intern Med. 2006;166:10031008.
  • 5
    Gure TR, Blaum CS, Giordani B, et al.Prevalence of cognitive impairment in older adults with heart failure. J Am Geriatr Soc. 2012;60:17241729.
  • 6
    Cameron J, Worrall-Carter L, Page K, et al.Does cognitive impairment predict poor self-care in patients with heart failure?Eur J Heart Fail. 2010;12:508515.
  • 7
    Gaviria M, Pliskin N, Kney A. Cognitive impairment in patients with advanced heart failure and its implications on decision-making capacity. Congest Heart Fail. 2011;17:175179.
  • 8
    Wilson CJ, Finch CE, Cohen HJ. Cytokines and cognition – the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc. 2002;50:20412056.
  • 9
    Anker SD, von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart. 2004;90:464470.
  • 10
    Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358:21482159.
  • 11
    Cannon JG. Inflammatory cytokines in nonpathological states. News Physiol Sci. 2000;15:298303.
  • 12
    Aukrust P, Gullestad L, Ueland T, et al.Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implication. Ann Med. 2005;37:7485.
  • 13
    Shioi T, Matsumori A, Kihara Y, et al.Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ Res. 1997;81:664671.
  • 14
    Singal PK, Khaper N, Palace V, et al.The role of oxidative stress in the genesis of heart disease. Cardiovasc Res. 1998;40:426432.
  • 15
    Araujo JP, Lourenco P, Azevedo A, et al.Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review. J Card Fail. 2009;15:256266.
  • 16
    McAfoose J, Baune BT. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev. 2009;33:355366.
  • 17
    Rauchhaus M, Doehner W, Francis DP, et al.Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 2000;102:30603067.
  • 18
    Athilingam P, King KB, Burgin WS, et al.Montreal cognitive assessment and mini mental status examination compared as cognitive screening tools in HF. Heart Lung. 2011;40:521529.
  • 19
    Levy D, Kenchaiah S, Larson MG, et al.Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:13971402.
  • 20
    Nasreddine ZS, Phillips NA, Bedirian V, et al.The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695699.
  • 21
    Cameron J, Worrall-Carter L, Page K, et al.Screening for mild cognitive impairment in patients with heart failure: Montreal Cognitive Assessment versus mini mental state exam. Eur J Cardiovasc Nurs. 2012 May 22. [Epub ahead of print].
  • 22
    Harkness K, Demers C, Heckman GA, McKelvie RS. Screening for cognitive deficits using the Montreal Cognitive Assessment tool in outpatients >=65 years of age with heart failure. Am J Cardiol. 2011;107:12031207.
  • 23
    McLennan S, Mathias J, Brennan L, Stewart S. Validity of the Montreal Cognitive Assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population. J Geriatr Psychiatry Neurol. 2011;24:3338. PMID: 21156989.
  • 24
    Jefferson AL. Cardiac output as a potential risk factor for abnormal brain aging. J Alzheimers Dis. 2010;20:803812.
  • 25
    Vogels RL, Oosterman JM, van Harten B, et al.Neuroimaging and correlates of cognitive function among patients with heart failure. Dement Geriatr Cogn Disord. 2007;24:418423.
  • 26
    Hoth KF, Poppas A, Moser DJ, et al.Cardiac dysfunction and cognition in older adults with heart failure. Cogn Behav Neurol. 2008;21:6572.
  • 27
    Festa JR, Jia X, Cheung K, et al.Association of low ejection fraction with impaired verbal memory in older patients with heart failure. Arch Neurol. 2011;68:1021. DOI: 10.1001/archneurol.2011.163.
  • 28
    Jesus PAP, Vieira-de-Melo RM, Reis FJFB, et al.Cognitive dysfunction in congestive heart failure: transcranial doppler evidence of microembolic etiology. Arq Neuropsiquiatr. 2006;64:207210.
  • 29
    Edouard AR, Vanhille E, Le Moigno S, et al.Non-invasive assessment of cerebral perfusion pressure in brain injured patients with moderate intracranial hypertension. Br J Anaesth. 2005;94:216221.
  • 30
    Bayram M, Yancy CW. Transthoracic impedance cardiograph: a noninvasive method of hemodynamic assessment. Heart Fail Clin. 2009;5:161168.
  • 31
    Suttner S, Schollhorn T, Boldt J, et al.Noninvasive assessment of cardiac output using thoracic electrical bioimpedance in hemodynamically stable and unstable patients after cardiac surgery: a comparison with pulmonary artery thermodilution. Intensive Care Med. 2011;37:1232. PMID: 17039348
  • 32
    Millan-Calenti JC, Tubio J, Pita-Fernandez S, et al.Prevalence of cognitive impairment: effects of level of education, age, sex and associated factors. Dement Geriatr Cogn Disord. 2009;28:455460.
  • 33
    Basta NE, Matthews FE, Chatfield MD, et al.Community-level socio-economic status and cognitive and functional impairment in the older population. Eur J Public Health. 2008;18:4854.
  • 34
    Joynt KE, Gattis WA, Hasselblad V, et al.Effect of angiotensin-converting enzyme inhibitors, beta-blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure. Am J Cardiol. 2004;93:783785.
  • 35
    Yesavage JA, Brink TL, Rose TL, et al.Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17:3749.
  • 36
    Miller MD, Paradis CF, Houck PR, et al.Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992;41:237248.
  • 37
    Guyatt GH, Sullivan MJ, Thompson PJ, et al.The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985;132:919923.
  • 38
    Russell DW. UCLA Loneliness Scale (Version 3): reliability, validity, and factor structure. J Pers Assess. 1996;66:2040.
  • 39
    Cohen J. A power primer. Psychol Bull. 1992;112:155159.
  • 40
    Suzuki H, Sato R, Sato T, et al.Time-course of changes in the levels of interleukin 6 in acutely decompensated heart failure. Int J Cardiol. 2005;100:415420.
  • 41
    Kosar F, Aksoy Y, Ozguntekin G, et al.Relationship between cytokines and tumour markers in patients with chronic heart failure. Eur J Heart Fail. 2006;8:270274.
  • 42
    Tassell BW, Varma A, Salloum FN, et al.Interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice. J Cardiovasc Pharmacol. 2010;55:117122.
  • 43
    Vasan RS, Sullivan LM, Roubenoff R, et al.Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation. 2003;107:14861491.
  • 44
    Wright CB, Sacco RL, Rundek TR, et al.Interleukin-6 is associated with cognitive function: the Northern Manhattan Study. J Stroke Cerebrovasc Dis. 2006;15:3438.
  • 45
    Dugan LL, Ali SS, Shekhtman G, et al.IL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidase. PLoS ONE. 2009;4:e5518.
  • 46
    Riegel B, Weaver TE. Poor sleep and impaired self-care: towards a comprehensive model linking sleep, cognition, and heart failure outcomes. Eur J Cardiovasc Nurs. 2009;8:337344.
  • 47
    Gunstad J, Poppas A, Smeal S, et al.Relation of brain natriuretic peptide levels to cognitive dysfunction in adults > 55 years of age with cardiovascular disease. Am J Cardiol. 2006;98:538540.
  • 48
    Gullestad L, Aukrust P, Ueland T, et al.Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. J Am Coll Cardiol. 1999;34:20612067.
  • 49
    Dowlati Y, Herrmann N, Swardfager W, et al.A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446457.
  • 50
    Morgan AL, Masoudi FA, Havranek EP, et al.Difficulty taking medications, depression, and health status in heart failure patients. J Card Fail. 2006;12:5460.